Cadrenal Therapeutics (CVKD) Q3 2025 Earnings

11AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.18
-2.03
-1.87
-1.72

Details

Expected EPS
-1.775
Actual EPS
-1.87
Surprise EPS
-0.1
Surprise Percent
+5.35%

Description

Cadrenal Therapeutics (CVKD) has reported earnings of -1.87 per share for Q3 2025.

0 Comments

Share your thoughts